Fibrinogen deficiency increases liver injury and early growth response-1 (Egr-1) expression in a model of chronic xenobiotic-induced cholestasis

American Journal of Pathology

Volumn 178, Issue 3, 2011, Pages 1117-1125

  Luyendyk, James P ^a   Kassel, Karen M ^a   Allen, Katryn ^a   Guo, Grace L ^a   Li, Guodong ^a   Cantor, Glenn H ^b   Copple, Bryan L ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 NAPHTHYL ISOTHIOCYANATE; ALANINE AMINOTRANSFERASE; BILE ACID; COLLAGEN; EARLY GROWTH RESPONSE FACTOR 1; FIBRIN; FIBRINOGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; XENOBIOTIC AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT; CHOLESTASIS; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; FIBRINOGEN DEFECT; GENE INDUCTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL DAMAGE; LIVER INJURY; LIVER NECROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION;

EID: 79952769474     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.11.064     Document Type: Article

References (44)

1. Perez MJ, Briz O: Bile-acid-induced cell injury and protection. World J Gastroenterol 2009, 15:1677-1689
2. Xia X, Demorrow S, Francis H, Glaser S, Alpini G, Marzioni M, Fava G, Lesage G: Cholangiocyte injury and ductopenic syndromes. Semin Liver Dis 2007, 27:401-412 (Pubitemid 350071840)
3. Alvaro D, Gigliozzi A, Attili AF: Regulation and deregulation of cholangiocyte proliferation. J Hepatol 2000, 33:333-340 (Pubitemid 30485240)
4. Pauli-Magnus C, Meier PJ: Hepatobiliary transporters and drug-induced cholestasis. Hepatology 2006, 44:778-787 (Pubitemid 46489540)
5. Lee J, Azzaroli F, Wang L, Soroka CJ, Gigliozzi A, Setchell KD, Kramer W, Boyer JL: Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. Gastroenterology 2001, 121:1473-1484 (Pubitemid 33140464)
6. Friedman SL: Mechanisms of hepatic fibrogenesis. Gastroenterology 2008, 134:1655-1669
7. Dietrich CG, Ottenhoff R, de Waart DR, Oude Elferink RP: Role of MRP2 and GSH in intrahepatic cycling of toxins. Toxicology 2001, 167:73-81 (Pubitemid 32830948)
8. Becker BA, Plaa GL: The nature of alpha-naphthylisothiocyanate-induced cholestasis. Toxicol Appl Pharmacol 1965, 7:680-685
9. Moritoki Y, Ueno Y, Kanno N, Yamagiwa Y, Fukushima K, Gershwin ME, Shimosegawa T: Lack of evidence that bone marrow cells contribute to cholangiocyte repopulation during experimental cholestatic ductal hyperplasia. Liver Int 2006, 26:457-466
10. Lesage G, Glaser S, Ueno Y, Alvaro D, Baiocchi L, Kanno N, Phinizy JL, Francis H, Alpini G: Regression of cholangiocyte proliferation after cessation of ANIT feeding is coupled with increased apoptosis. Am J Physiol Gastrointest Liver Physiol 2001, 281:G182-G190
11. Tjandra K, Sharkey KA, Swain MG: Progressive development of a Th1-type hepatic cytokine profile in rats with experimental cholangitis. Hepatology 2000, 31:280-290 (Pubitemid 30078589)
12. Xu J, Lee G, Wang H, Vierling JM, Maher JJ: Limited role for CXC chemokines in the pathogenesis of alpha-naphthylisothiocyanate-induced liver injury. Am J Physiol Gastrointest Liver Physiol 2004, 287:G734-G741 (Pubitemid 39096641)
13. Segal H, Cottam S, Potter D, Hunt BJ: Coagulation and fibrinolysis in primary biliary cirrhosis compared with other liver disease and during orthotopic liver transplantation. Hepatology 1997, 25:683-688 (Pubitemid 27106454)
14. Ben-Ari Z, Panagou M, Patch D, Bates S, Osman E, Pasi J, Burroughs A: Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. J Hepatol 1997, 26:554-559 (Pubitemid 27112720)
15. Kloek JJ, Heger M, van der Gaag NA, Beuers U, van Gulik TM, Gouma DJ, Levi M: Effect of preoperative biliary drainage on coagulation and fibrinolysis in severe obstructive cholestasis. J Clin Gastroenterol 2010, 44:646-652
16. Bergheim I, Guo L, Davis MA, Duveau I, Arteel GE: Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis. J Pharmacol Exp Ther 2006, 316:592-600 (Pubitemid 43130985)
17. Luyendyk JP, Cantor GH, Kirchhofer D, Mackman N, Copple BL, Wang R: Tissue factor-dependent coagulation contributes to alpha-naphthylisothiocyanate- induced cholestatic liver injury in mice. Am J Physiol Gastrointest Liver Physiol 2009, 296:G840-G849
18. Wang H, Vohra BP, Zhang Y, Heuckeroth RO: Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice. Hepatology 2005, 42:1099-1108 (Pubitemid 43112677)
19. Wang H, Zhang Y, Heuckeroth RO: PAI-1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA. FEBS Lett 2007, 581:3098-3104 (Pubitemid 46899037)
20. Wang H, Zhang Y, Heuckeroth RO: Tissue-type plasminogen activator deficiency exacerbates cholestatic liver injury in mice. Hepatology 2007, 45:1527-1537 (Pubitemid 46918337)
21. Suh TT, Holmbäck K, Jensen NJ, Daugherty CC, Small K, Simon DI, Potter SS, Degen JL: Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev 1995, 9:2020-2033
22. Weiler-Guettler H, Christie PD, Beeler DL, Healy AM, Hancock WW, Rayburn H, Edelberg JM, Rosenberg RD: A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J Clin Invest 1998, 101:1983-1991 (Pubitemid 28226118)
23. Brulet P, Babinet C, Kemler R, Jacob F: Monoclonal antibodies against trophectoderm-specific markers during mouse blastocyst formation. Proc Natl Acad Sci U S A 1980, 77:4113-4117 (Pubitemid 10022559)
24. Luyendyk JP, Sullivan BP, Guo GL, Wang R: Tissue factor deficiency and protease activated receptor-1 deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice. Am J Pathol 2010, 176:177-186
25. Kim ND, Moon JO, Slitt AL, Copple BL: Early growth response factor-1 is critical for cholestatic liver injury. Toxicol Sci 2006, 90:586-595
26. Copple BL, Woolley B, Banes A, Ganey PE, Roth RA: Anticoagulants prevent monocrotaline-induced hepatic parenchymal cell injury but not endothelial cell injury in the rat. Toxicol Appl Pharmacol 2002, 180:186-196 (Pubitemid 34526459)
27. Allen K, Kim ND, Moon JO, Copple BL: Upregulation of early growth response factor-1 by bile acids requires mitogen-activated protein kinase signaling. Toxicol Appl Pharmacol 2010, 243:63-67
28. Shi L, Kishore R, McMullen MR, Nagy LE: Lipopolysaccharide stimulation of ERK1/2 increases TNF-alpha production via Egr-1. Am J Physiol Cell Physiol 2002, 282:C1205-C1211 (Pubitemid 34663068)
29. Ganey PE, Luyendyk JP, Newport SW, Eagle TM, Maddox JF, Mackman N, Roth RA: Role of the coagulation system in acetaminophen-induced hepatotoxicity in mice. Hepatology 2007, 46:1177-1186 (Pubitemid 350144782)
30. Pearson JM, Schultze AE, Schwartz KA, Scott MA, Davis JM, Roth RA: The thrombin inhibitor, hirudin, attenuates lipopolysaccharide-induced liver injury in the rat. J Pharmacol Exp Ther 1996, 278:378-383 (Pubitemid 27167117)
31. Abdel-Salam OM, Baiuomy AR, Ameen A, Hassan NS: A study of unfractionated and low molecular weight heparins in a model of cholestatic liver injury in the rat. Pharmacol Res 2005, 51:59-67 (Pubitemid 39425074)
32. Rullier A, Gillibert-Duplantier J, Costet P, Cubel G, Haurie V, Petibois C, Taras D, Dugot-Senant N, Deleris G, Bioulac-Sage P, Rosenbaum J: Protease-activated receptor 1 knockout reduces experimentally induced liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2008, 294:G226-G235 (Pubitemid 351164861)
33. Fiorucci S, Antonelli E, Distrutti E, Severino B, Fiorentina R, Baldoni M, Caliendo G, Santagada V, Morelli A, Cirino G: PAR1 antagonism protects against experimental liver fibrosis: role of proteinase receptors in stellate cell activation. Hepatology 2004, 39:365-375 (Pubitemid 38222177)
34. Copple BL, Moulin F, Hanumegowda UM, Ganey PE, Roth RA: Thrombin and protease-activated receptor-1 agonists promote lipopolysaccharide- induced hepatocellular injury in perfused livers. J Pharmacol Exp Ther 2003, 305:417-425 (Pubitemid 36459153)
35. Neubauer K, Knittel T, Armbrust T, Ramadori G: Accumulation and cellular localization of fibrinogen/fibrin during short-term and longterm rat liver injury. Gastroenterology 1995, 108:1124-1135
36. Chen YP, O'Toole TE, Leong L, Liu BQ, az-Gonzalez F, Ginsberg MH: Beta 3 integrin-mediated fibrin clot retraction by nucleated cells: differing behavior of alpha IIb beta 3 and alpha v beta 3. Blood 1995, 86:2606-2615
37. Merono A, Lucena C, Lopez A, Garrido JJ, Perez de LL, Llanes D: Immunohistochemical analysis of beta3 integrin (CD61): expression in pig tissues and human tumors. Histol Histopathol 2002, 17:347-352 (Pubitemid 34411192)
38. Patsenker E, Popov Y, Stickel F, Schneider V, Ledermann M, Sagesser H, Niedobitek G, Goodman SL, Schuppan D: Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis. Hepatology 2009, 50:1501-1511
39. Kinugasa T, Uchida K, Kadowaki M, Takase H, Nomura Y, Saito Y: Effect of bile duct ligation on bile acid metabolism in rats. J Lipid Res 1981, 22:201-207 (Pubitemid 11125124)
40. Keitel V, Donner M, Winandy S, Kubitz R, Haussinger D: Expression and function of the bile acid receptor TGR5 in Kupffer cells. Biochem Biophys Res Commun 2008, 372:78-84 (Pubitemid 351778164)
41. Calmus Y, Guechot J, Podevin P, Bonnefis MT, Giboudeau J, Poupon R: Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor-alpha production by monocytes. Hepatology 1992, 16:719-723
42. Sung JJ, Go MY: Reversible Kupffer cell suppression in biliary obstruction is caused by hydrophobic bile acids. J Hepatol 1999, 30: 413-418 (Pubitemid 29113229)
43. Luyendyk JP, Mackman N, Sullivan BP: Role of fibrinogen and protease activated receptors in acute xenobiotic-induced cholestatic liver injury. Toxicol Sci 2011, 119:233-243
44. Lisman T, Caldwell SH, Burroughs AK, Northup PG, Senzolo M, Stravitz RT, Tripodi A, Trotter JF, Valla DC, Porte RJ: Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol 2010, 53:362-371